Novartis AG will license a messenger RNA-based autoimmune therapy from China’s Abogen Biosciences, in a deal worth as much as $7. 8 billion.
Source: [Bloomberg Markets](https://www.bloomberg.com/news/articles/2026-10-02/novartis-inks-chinese-mrna-therapy-deal-for-up-to-7-8-billion)